Aleš Obr

6PUBLICATIONS
97CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 12, 2022
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic.

Ales Obr, Katerina Benesova, Andrea Janikova

|Oct 15, 2021
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

Livio Pagano, Jon Salmanton-García, Francesco Marchesi

|Aug 06, 2020
Concurrent TP53 and CDKN2A Gene Aberrations in Newly Diagnosed Mantle Cell Lymphoma Correlate with Chemoresistance and Call for Innovative Upfront Therapy.

Diana Malarikova, Adela Berkova, Ales Obr

|Sep 07, 2018
Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†.

Aleš Obr, Vit Prochazka, Tomas Papajik

Pageof 1

Frequent Collaborators

2 joint publications

Pavel Klener

1 joint publications

Michael Svaton

1 joint publications

Eva Kriegova

1 joint publications

Livio Pagano